180 related articles for article (PubMed ID: 15831713)
1. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation.
Miller ME; Michaylira CZ; Simmons JG; Ney DM; Dahly EM; Heath JK; Lund PK
Gastroenterology; 2004 Aug; 127(2):570-81. PubMed ID: 15300589
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
[TBL] [Abstract][Full Text] [Related]
4. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
[TBL] [Abstract][Full Text] [Related]
5. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts.
Simmons JG; Pucilowska JB; Keku TO; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G809-18. PubMed ID: 12181198
[TBL] [Abstract][Full Text] [Related]
6. Knock your SOCS off!
Leroith D; Nissley P
J Clin Invest; 2005 Feb; 115(2):233-6. PubMed ID: 15690080
[TBL] [Abstract][Full Text] [Related]
7. Enterotrophic effect of insulin-like growth factor-I but not growth hormone and localized expression of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and -5 mRNAs in jejunum of parenterally fed rats.
Peterson CA; Gillingham MB; Mohapatra NK; Dahly EM; Adamo ML; Carey HV; Lund PK; Ney DM
JPEN J Parenter Enteral Nutr; 2000; 24(5):288-95. PubMed ID: 11011784
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of suppressors of cytokine signalling genes in response to nutrition and growth hormone in the septic rat.
Johnson TS; O'Leary M; Justice SK; Maamra M; Zarkesh-Esfahani SH; Furlanetto R; Preedy VR; Hinds CJ; El Nahas AM; Ross RJ
J Endocrinol; 2001 May; 169(2):409-15. PubMed ID: 11312157
[TBL] [Abstract][Full Text] [Related]
9. The effect of growth factor signaling on keratocytes in vitro and its relationship to the phases of stromal wound repair.
Etheredge L; Kane BP; Hassell JR
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3128-36. PubMed ID: 19234354
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions.
Williams KL; Fuller CR; Fagin J; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G875-85. PubMed ID: 12223347
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation.
Theiss AL; Fuller CR; Simmons JG; Liu B; Sartor RB; Lund PK
Gastroenterology; 2005 Jul; 129(1):204-19. PubMed ID: 16012948
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of maternal lactation performance during prolonged lactation in the mouse by mouse GH and long-R3-IGF-I is linked to changes in mammary signaling and gene expression.
Hadsell DL; Parlow AF; Torres D; George J; Olea W
J Endocrinol; 2008 Jul; 198(1):61-70. PubMed ID: 18577570
[TBL] [Abstract][Full Text] [Related]
13. The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats.
Hursting SD; Switzer BR; French JE; Kari FW
Cancer Res; 1993 Jun; 53(12):2750-7. PubMed ID: 8389243
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
15. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
16. Gigantism in mice lacking suppressor of cytokine signalling-2.
Metcalf D; Greenhalgh CJ; Viney E; Willson TA; Starr R; Nicola NA; Hilton DJ; Alexander WS
Nature; 2000 Jun; 405(6790):1069-73. PubMed ID: 10890450
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds.
Hamon GA; Hunt TK; Spencer EM
Growth Regul; 1993 Mar; 3(1):53-6. PubMed ID: 7683531
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone and insulin-like growth factor-I on the proliferation and differentiation of cultured pig bone cells and rat calvaria cells.
Denis I; Pointillart A; Lieberherr M
Growth Regul; 1994 Sep; 4(3):123-30. PubMed ID: 7858485
[TBL] [Abstract][Full Text] [Related]
19. Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone.
Ney DM; Huss DJ; Gillingham MB; Kritsch KR; Dahly EM; Talamantez JL; Adamo ML
Endocrinology; 1999 Oct; 140(10):4850-60. PubMed ID: 10499545
[TBL] [Abstract][Full Text] [Related]
20. The effect of growth hormone on fibroblast proliferation and keratinocyte migration.
Lee SW; Kim SH; Kim JY; Lee Y
J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):e364-9. PubMed ID: 20022575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
